CLVLF Earnings
Clinuvel Pharmaceuticals Limited
1W: -3.6%
1M: -3.4%
3M: -6.9%
YTD: -26.2%
1Y: -28.1%
3Y: -39.2%
5Y: -80.8%
$5.68
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-08-26
EPS
A$0.33 (US$0.23)
▼ Miss -6.1%
Revenue
A$40M ($27M)
▼ Miss -4.8%
Estimate vs Actual
Earnings Surprise History
4/20
EPS Beats
3/20
Revenue Beats
20%
EPS Beat Rate
15%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2027-06-30 | A$0.69 | A$0.68 | ▼ 0.01 | A$95,611,530 | A$95,072,187 |
| 2026-10-02 | annual | 2028-06-30 | A$0.71 | A$0.71 | — | A$102,064,183 | A$101,488,441 |
| 2026-10-02 | annual | 2029-06-30 | A$1.02 | A$1.02 | — | A$139,735,331 | A$138,947,086 |
| 2026-10-02 | annual | 2030-06-30 | A$3.97 | A$3.95 | ▼ 0.02 | A$379,872,412 | A$377,729,559 |
| 2026-10-01 | annual | 2027-06-30 | A$0.69 | A$0.69 | — | A$96,055,051 | A$95,611,530 |
| 2026-10-01 | annual | 2028-06-30 | A$0.72 | A$0.71 | ▼ 0.01 | A$102,537,636 | A$102,064,183 |
| 2026-10-01 | annual | 2029-06-30 | A$1.03 | A$1.02 | ▼ 0.01 | A$140,383,532 | A$139,735,331 |
| 2026-10-01 | annual | 2030-06-30 | A$3.99 | A$3.97 | ▼ 0.02 | A$381,634,556 | A$379,872,412 |
| 2026-09-30 | annual | 2027-06-30 | A$0.69 | A$0.69 | — | A$96,137,184 | A$96,055,051 |
| 2026-09-30 | annual | 2028-06-30 | A$0.72 | A$0.72 | — | A$102,625,312 | A$102,537,636 |
| 2026-09-30 | annual | 2029-06-30 | A$1.03 | A$1.03 | — | A$140,503,569 | A$140,383,532 |
| 2026-09-30 | annual | 2030-06-30 | A$4.00 | A$3.99 | ▼ 0.01 | A$381,960,878 | A$381,634,556 |
| 2026-09-29 | annual | 2030-06-30 | A$3.99 | A$4.00 | ▲ 0.01 | A$381,286,478 | A$381,960,878 |
| 2026-09-29 | annual | 2029-06-30 | A$1.03 | A$1.03 | — | A$140,255,492 | A$140,503,569 |
| 2026-09-29 | annual | 2028-06-30 | A$0.72 | A$0.72 | — | A$102,444,114 | A$102,625,312 |
Earnings Call Transcripts
No transcripts available.